ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
ETC 6 Meridian Hedged Equity Index Option ETF

ETC 6 Meridian Hedged Equity Index Option ETF (SIXH)

37.38
0.10
( 0.27% )
Updated: 10:05:04

Empower your portfolio: Real-time discussions and actionable trading ideas.

SIXH News

Official News Only

Discussion

View Full Feed
Donotunderstand Donotunderstand 2 minutes ago
one hour in approximately

2/3rds of daily average volume (I do not know how the typical day looks at this point - but 66% seems high and strong)

?
NKLA
$Gambler $Gambler 2 minutes ago
It's definitely a start from Greg, also it did specify the co-host opportunities that this merger can create. Now that filing has been amended I feel like we will be getting updates more regularly from new CEO. Yield might come down tomorrow and all the restraints will be removed, onward, upward fri
CGAC
Gnewton14 Gnewton14 2 minutes ago
Knw
BigBadWolf BigBadWolf 2 minutes ago
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175514005&txt2find=outstanding
AXXA
Carjockey2 Carjockey2 2 minutes ago
One tick flippers please exit to the right best to have them out now then later there are literally Traders with millions of shares here..

Good for them if they make money it's not easy to do all the time on the OTC.
HMBL
manibiotech manibiotech 3 minutes ago
He has no clue
NWBO
TKS PARTY TKS PARTY 3 minutes ago
Maybe this gem is holding things up ! Dshade Oct 3rd
CBRF
PonkenPlonken PonkenPlonken 3 minutes ago
go go
CADL
iclight iclight 3 minutes ago
Why do you always reply to a post with something that has absolutely nothing to do with that post. Flaskworks is irrelevant to approval. And if it was you would be waiting another few years for a comparability study to be run. Actually in NWBO time, another 15 years.
NWBO
Doubledown75 Doubledown75 3 minutes ago
$bleg?
Has volume spike now!!
BLEG
MightyX MightyX 3 minutes ago
Not all shareholders are stakeholders involved in launch
TPTW
MoneyMan MoneyMan 3 minutes ago
The CEO of $CEOS was on Fox News last night. Meetings at Mar-a-Lago starting today.
https://x.com/KateMonroeCEO/status/1867094941257601519
CEOS
DrSleep DrSleep 3 minutes ago
Avg cost $0.60. Just got in the game
ELTP
al44 al44 3 minutes ago
Alvin Bragg’s Final Gambit

The Manhattan DA takes opportunities for justice off the table.

by Mark Angelides | Dec 12, 2024


Manhattan District Attorney Alvin Bragg presented possible options this week for handling the sentencing of former and fut
Yooperman Yooperman 3 minutes ago
Time will tell.
TSOI
manibiotech manibiotech 3 minutes ago
Going by Thermo's past implicit predictions , his /her answer is irrelevant to the market and investors in my opinion 
NWBO
BeachBum BeachBum 3 minutes ago
Make up your mind Kiss. Remember, you can’t chart OTC stocks. Your words. The chart shows .004. When is a guess. Could happen today, next week or next year.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175010215&txt2find=Chart
AHRO
MoneyMan MoneyMan 4 minutes ago
The CEO of $CEOS was on Fox News last night. Meetings at Mar-a-Lago starting today.
https://x.com/KateMonroeCEO/status/1867094941257601519
CEOS
Samuel J Samuel J 4 minutes ago
Energizer Battery Keeps Going and Going!

This is free Yuk Yuk's right here on ihub! Can't script this boys and girls. 

Next 10 pages 😂 
AZRH
fredscott36 fredscott36 4 minutes ago
DID WE SETTLE OUR SONTERRA/libor appeal for $364mm, using the amended petition process, at the USCA level...............????.................

I ain't got no answer to that query......I'm a cattle cowboy from MORA, MISSOURI....................dope and rope, as it were.......and, if my
JusDePomme JusDePomme 4 minutes ago
Hopefully .0015+ closing bell
HMBL
Doubledown75 Doubledown75 4 minutes ago
Something going on?
BLEG
qualityincolor qualityincolor 4 minutes ago
GTSM needs to go
RDAR
mailman69 mailman69 4 minutes ago
That's a possibility
VXIT
cintrix cintrix 4 minutes ago
KROS down 77% Keros Therapeutics' market value dived after the biopharmaceutical company said it halted dosing in a trial of a treatment for pulmonary arterial hypertension following unexpected, adverse pericardial-effusion events.
KROS